34 related articles for article (PubMed ID: 11849474)
21. Impaired proteolytic activity as a potential cause of progressive renal disease.
Heidland A; Ling H; Vamvakas S; Paczek L
Miner Electrolyte Metab; 1996; 22(1-3):157-61. PubMed ID: 8676810
[TBL] [Abstract][Full Text] [Related]
22. Hepatorenal syndrome. A review.
Altman KA
Am J Gastroenterol; 1968 May; 49(5):436-9. PubMed ID: 4297522
[No Abstract] [Full Text] [Related]
23. The angiotensin II type 2 receptor in renal disease.
Wenzel UO; Krebs C; Benndorf R
J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):37-41. PubMed ID: 19861345
[TBL] [Abstract][Full Text] [Related]
24. Converting enzyme inhibitors: structural and hemodynamic effects on failing kidney.
Stella A; Buccianti G
Am J Kidney Dis; 1991 May; 17(5 Suppl 1):81-4. PubMed ID: 2024681
[No Abstract] [Full Text] [Related]
25. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.
Blankstein R; Bakris GL
Heart Fail Clin; 2008 Oct; 4(4):425-38. PubMed ID: 18760754
[TBL] [Abstract][Full Text] [Related]
26. Impact of renin-angiotensin system blockade on structure and function of glomerular membrane components in animal models of kidney disease.
Remuzzi A; Mohamed EI
Exp Nephrol; 1996; 4 Suppl 1():27-33. PubMed ID: 9001894
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
Wolf G
Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?
Ketteler M; Noble NA; Border WA
Annu Rev Physiol; 1995; 57():279-95. PubMed ID: 7778869
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II as a mediator of tubulointerstitial injury.
Wolf G
Nephrol Dial Transplant; 2000; 15 Suppl 6():61-3. PubMed ID: 11143994
[No Abstract] [Full Text] [Related]
30. Can angiotensin II be used for renoprotection?
de Zeeuw D
Kidney Int; 2002 Mar; 61(3):1176-7. PubMed ID: 11849474
[No Abstract] [Full Text] [Related]
31. [Renin-angiotensin system in kidney physiology and pathology].
Łapiński R
Postepy Hig Med Dosw; 2000; 54(5):639-56. PubMed ID: 11146891
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II: a pivotal factor in the progression of renal diseases.
Wolf G
Nephrol Dial Transplant; 1999; 14 Suppl 1():42-4. PubMed ID: 10048448
[No Abstract] [Full Text] [Related]
33. Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
Dussaule JC; Chatziantoniou C
Cell Death Differ; 2007 Jul; 14(7):1343-9. PubMed ID: 17396129
[TBL] [Abstract][Full Text] [Related]
34. [Angiotensin-converting enzyme inhibitors: effects on renal physiology and applications in hypertension and renal disease].
Cofán F; Romero R
Rev Clin Esp; 1993 Jan; 192(1):31-8. PubMed ID: 8465029
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
